#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12594	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2165	574.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1678	1678	T	741	T	713	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12594	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2165	574.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	708	C	687	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23730	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3517	669.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1624	1624	A	807	A,G	790,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23730	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3517	669.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2258	2258	C	757	C	733	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23730	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3517	669.4	0	.	n	.	0	C2847T	SNP	2847	2847	C	3134	3134	T	694	T,C	510,174	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23730	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3517	669.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2332	2332	A	777	A,C	761,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23730	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3517	669.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2884	2884	C	716	C	702	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	18	blaTEM	861	232	100.0	blaTEM.l6.c4.ctg.1	234	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1842	folP	855	855	99.88	folP.l15.c4.ctg.1	1627	112.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1085	1087	AGC	175;174;175	A;G;C	172;173;174	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5254	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3354	155.6	0	.	p	.	0	G95A	NONSYN	283	285	GGC	594	596	GCC	186;186;186	G;C;C	183;183;181	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5254	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3354	155.6	1	SNP	p	S91F	1	.	.	271	273	TTC	582	584	TTC	185;185;185	T;T;C	182;180;184	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1618	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1384	116.0	0	.	p	.	0	A39T	NONSYN	115	117	GCC	450	452	ACC	191;188;185	A;C;C	183;182;178	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1618	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1384	116.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	648	650	CAC	202;202;203	C;A;C	199;187;200	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1618	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1384	116.0	0	.	p	.	0	A127fs	FSHIFT	379	379	G	714	714	G	185	G	179	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1618	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1384	116.0	1	SNP	p	G45D	0	.	.	133	135	GGC	468	470	GGC	185;185;184	G;G;C	176;175;176	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	832	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	990	82.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4386	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2944	147.9	0	.	p	.	0	S87N	NONSYN	259	261	AGT	494	496	AAT	157;157;160	A,G;A;T	151,1;153;154	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4386	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2944	147.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1385	1387	GTC	205;206;205	G;T;C	198;198;198	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4386	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2944	147.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1538	1540	GCA	192;190;192	G;C,G;A	187;171,1;176	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4386	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2944	147.9	1	SNP	p	D86N	0	.	.	256	258	GAC	491	493	GAC	159;155;162	G;A;C	156;149;155	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4386	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2944	147.9	1	SNP	p	S88P	0	.	.	262	264	TCC	497	499	TCC	161;162;163	T;C;C	153;159;159	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3546	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2731	128.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1606	1608	GGC	166;163;165	G;G;C	163;159;160	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1218	1220	GCA	192;192;194	G;C;A	185;178;189	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1221	1223	ATC	195;195;198	A;T;C	190;192;194	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1233	1235	GTG	192;191;192	G;T;G,T	187;185;185,1	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1233	1235	GTG	192;191;192	G;T;G,T	187;185;185,1	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1737	1739	ACC	171;171;173	A;C;C	161;165;167	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1791	1793	GCG	166;163;164	G;C,G;G	160;136,3;154	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1791	1793	GCG	166;163;164	G;C,G;G	160;136,3;154	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1914	1916	GGT	134;133;130	G;G;T	132;130;125	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1923	1925	GGC	128;127;126	G;G;C	127;124;123	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3410	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2401	140.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1941	1943	CCG	113;115;119	C,G;C;G	91,5;94;97	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5086	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3121	161.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1642	1644	CCG	181;180;181	C,T;C;G	170,1;173;172	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2298	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1743	130.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	576	576	C	173	C	158	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	444	446	GAA	208;206;209	G;A;A	203;202;204	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	D121G	NONSYN	361	363	GAC	693	695	GGC	196;194;192	G;G;C	190;187;185	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	855	857	TCA	206;205;205	T;C;A	199;197;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	891	893	CAA	201;203;201	C;A;A	196;194;194	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	G189S	NONSYN	565	567	GGC	897	899	AGC	207;208;209	A;G;C	199;201;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	F215T	NONSYN	643	645	TTT	975	977	ACT	181;183;183	A;C;T,G	178;180;181,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	984	986	GTG	181;180;179	G;T;G,C	178;174;175,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	A242V	NONSYN	724	726	GCC	1056	1058	GTT	184;187;186	G;T;T	178;179;178	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	W257S	NONSYN	769	771	TGG	1101	1103	TCG	177;179;174	T;C;G	169;171;164	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	0	.	p	.	0	V293A	NONSYN	877	879	GTT	1209	1211	GCT	174;176;176	G;C;T,A	168;172;170,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1589	151.4	1	SNP	p	G120K	1	.	.	358	360	AAG	690	692	AAG	201;199;200	A;A;G	194;192;190	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8734	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4820	179.9	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1994	1996	AAT	177;177;178	A;A;T	173;173;172	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	910	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1088	83.0	1	SNP	p	V57M	1	.	.	169	171	ATG	575	577	ATG	175;180;178	A;T;G	171;177;173	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	M177T	NONSYN	529	531	ATG	886	888	ACG	297;297;298	A,C;C;G,T	291,1;294;293,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	907	909	GAC	283;284;285	G;A;C	280;282;285	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	T190M	NONSYN	568	570	ACG	925	927	ATG	271;273;277	A;T;G	269;270;276	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	L194S	NONSYN	580	582	TTA	937	939	TCA	272;272;276	T;C;A	270;269;274	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	982	984	CAG	299;302;303	C;A;G,T	297;300;301,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1003	1005	CTT	272;271;270	C;T,C;T	270;268,1;269	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1024	1026	AGT	286;287;287	A;G;T	284;283;282	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1093	1095	CCG	362;365;369	C;C;G	355;357;361	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1195	1197	TCG	329;328;325	T;C;G	323;322;317	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1366	1368	AAA	224;220;221	A;A;A	216;213;214	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1369	1371	AAG	220;217;219	A;A;G,T	214;210;210,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1384	1386	CAC	196;196;194	C;A,C;C	195;186,1;194	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1423	1425	GAA	203;202;201	G;A;A	202;202;200	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1501	1503	ACG	132;132;128	A;C;G	132;131;125	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1552	1554	ATT	161;161;159	A;T;T	160;160;159	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1555	1557	AGT	160;158;157	A;G;T	160;157;151	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1594	1596	CTA	182;182;184	C;T;A	180;180;182	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1636	1638	AAT	117;118;119	A,G;A;T	115,1;117;117	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1705	1707	TCA	198;200;205	T;C;A	198;200;197	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1729	1731	ATG	223;223;221	A;T;G	221;221;220	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2023	2025	ACC	392;393;398	A;C;C	382;388;392	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7276	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2673	270.4	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2119	2121	GAA	396;397;396	G;A,T;A	388;386,1;389	.	Tetracycline resistance
